Health IT Analytics |
SGLT1/2 Inhibitor Sotagliflozin 'Encouraging' in Type 1 Diabetes
Medscape SAN DIEGO — Discussing data on the investigational oral agent sotagliflozin — a first-in-class, oral dual inhibitor of both sodium-glucose cotransporter types 1 and 2 (SGLT1 and SGLT2) — for the treatment of type 1 diabetes, doctors at the American ... mHealth, Socioeconomic Data Address Diabetes Care Disparities |
![[OC] Build Your Own Dexcom App update- base version updates](https://4.bp.blogspot.com/-O3EpVMWcoKw/WxY6-6I4--I/AAAAAAAAB2s/KzC0FqUQtkMdw7VzT6oOR_8vbZO6EJc-ACK4BGAYYCw/w680/nth.png)
Social Plugin